Profile data is unavailable for this security.
About the company
Bure Equity AB is a Sweden-based investment company. The Company specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
- Revenue in SEK (TTM)188.00m
- Net income in SEK5.32bn
- Incorporated1992
- Employees9.00
- LocationBure Equity ABNybrogatan 6STOCKHOLM 114 34SwedenSWE
- Phone+46 86140020
- Fax+46 86140038
- Websitehttps://www.bure.se/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Svolder AB | 507.70m | 484.70m | 6.43bn | 5.00 | 13.64 | 1.01 | -- | 12.67 | 4.56 | 4.56 | 5.00 | 61.63 | 0.0824 | -- | 73.05 | 101,540,000.00 | 7.87 | 10.20 | 7.92 | 10.26 | 94.07 | 96.56 | 95.47 | 94.54 | -- | -- | 0.00 | 15.09 | 57.64 | -- | 55.69 | -- | 0.00 | 14.87 |
| eQ Oyj | 817.83m | 355.64m | 6.52bn | 100.00 | 18.55 | 10.83 | 17.61 | 7.97 | 0.7306 | 0.7306 | 1.68 | 1.25 | 0.6303 | -- | 91.29 | 696,891.10 | 27.41 | 31.07 | 29.94 | 37.81 | 98.90 | 99.25 | 43.49 | 44.88 | -- | -- | 0.0841 | 102.65 | -8.67 | 9.36 | -13.21 | 12.11 | -25.33 | 8.18 |
| Creades publ AB | 1.11bn | 1.09bn | 7.44bn | 8.00 | 9.92 | 1.12 | -- | 6.73 | 8.06 | 8.06 | 8.14 | 71.37 | 0.1166 | -- | 17.54 | 157,857,100.00 | 11.54 | 13.15 | 11.80 | 13.38 | -- | -- | 99.00 | 93.42 | -- | -- | 0.0011 | 12.58 | 112.11 | -16.86 | 114.13 | 1.03 | -- | 2.71 |
| MedCap AB (publ) | 1.67bn | 203.30m | 8.78bn | 512.00 | 43.39 | 8.03 | 28.31 | 5.26 | 13.67 | 13.67 | 112.19 | 73.85 | 1.03 | 3.40 | 6.01 | 3,506,093.00 | 12.52 | 9.01 | 15.94 | 12.00 | 47.69 | 46.77 | 12.21 | 9.84 | 1.48 | 40.27 | 0.2052 | 0.00 | 42.84 | 17.49 | 46.43 | 47.82 | 2.82 | -- |
| Ratos AB | 32.87bn | 1.29bn | 12.05bn | 11.05k | 9.19 | 1.14 | 2.71 | 0.3667 | 3.91 | 3.91 | 100.16 | 31.54 | 0.9078 | 8.23 | 5.63 | 2,973,584.00 | 5.87 | 3.39 | 9.29 | 5.11 | 44.60 | 40.22 | 6.47 | 4.06 | 0.6697 | 2.07 | 0.4151 | 44.71 | 12.96 | 7.85 | 122.26 | -- | -15.01 | 20.11 |
| Kinnevik AB | 491.00m | -8.41bn | 25.09bn | 46.00 | -- | 0.6472 | -- | 51.09 | -29.86 | -29.86 | 1.74 | 139.77 | 0.009 | -- | -- | 10,673,910.00 | -15.36 | 13.28 | -17.00 | 13.51 | -- | -- | -1,712.02 | 486.46 | -- | 0.0129 | 0.083 | -- | -73.54 | -13.08 | 75.58 | -- | -- | -- |
| Bure Equity AB | 188.00m | 5.32bn | 28.78bn | 9.00 | 5.43 | 1.30 | 5.41 | 153.11 | 71.55 | 71.55 | 2.53 | 298.19 | 0.0096 | -- | 376.00 | 18,800,000.00 | 27.15 | 11.10 | 27.21 | 11.14 | 82.45 | 78.76 | 2,828.72 | 800.92 | -- | -- | 0.00009 | 8.96 | -6.91 | -13.43 | 151.34 | 21.12 | -- | 4.56 |
| Avanza Bank Holding AB | 5.17bn | 2.07bn | 37.58bn | 677.00 | 18.15 | 7.33 | 17.40 | 7.27 | 13.17 | 13.17 | 32.86 | 32.61 | 0.0175 | -- | -- | 7,815,431.00 | 0.7025 | 0.6902 | 0.8842 | 0.8851 | 70.00 | 81.72 | 40.09 | 46.06 | -- | -- | 0.9237 | 65.53 | 36.60 | 28.34 | 18.97 | 41.53 | -0.8131 | 40.51 |
| Storebrand ASA | -4.26bn | 4.45bn | 48.09bn | 2.25k | 10.78 | 1.61 | 9.76 | -- | 10.19 | 10.19 | -9.73 | 68.14 | -0.0048 | -- | -- | -1,941,255.00 | 0.4993 | 0.3656 | -- | -- | -- | -- | -- | 4.19 | -- | -- | 0.6303 | 50.71 | -101.59 | -- | 41.83 | -1.88 | 29.40 | 6.45 |
| L E Lundbergforetagen AB (publ) | 28.58bn | 8.61bn | 81.62bn | 4.20k | 15.48 | 1.18 | 7.35 | 2.86 | 34.68 | 34.68 | 114.89 | 453.53 | 0.1314 | -- | -- | 6,799,239.00 | 4.45 | 5.61 | 6.40 | 8.03 | -- | 57.41 | 33.83 | 42.68 | 1.03 | -- | 0.1127 | 13.18 | -1.81 | 7.23 | 379.19 | 15.11 | 6.69 | 6.09 |
| Holder | Shares | % Held |
|---|---|---|
| AMF Fonder ABas of 31 Dec 2023 | 7.35m | 9.92% |
| Fj�rde AP-fondenas of 31 Dec 2023 | 5.81m | 7.84% |
| SEB Investment Management ABas of 28 Jun 2024 | 4.31m | 5.81% |
| The Vanguard Group, Inc.as of 04 Jul 2024 | 1.92m | 2.60% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.38m | 1.86% |
| Dimensional Fund Advisors LPas of 31 May 2024 | 1.24m | 1.67% |
| F�rsta AP-fondenas of 31 Dec 2023 | 1.20m | 1.62% |
| Handelsbanken Fonder ABas of 30 Jun 2024 | 805.61k | 1.09% |
| BlackRock Fund Advisorsas of 04 Jul 2024 | 720.58k | 0.97% |
| American Century Investment Management, Inc.as of 03 Jul 2024 | 556.92k | 0.75% |
